Raf Moons

TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium.

BNP Paribas Fortis Private Equity Belgium NV is a Private Equity/Venture Capital firm, a subsidiary of BNP Paribas Fortis SA/NV founded in 1981. BNP Paribas Fortis Private Equity Belgium NV is headquartered in Brussels.

Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain.

Outside Broadcast NV provides television broadcasting services. It offers It develops corporate movies, instructional videos, commercials, and product placement videos; and supplies camera crews for news coverage and featured news. The company was founded in 1989 and is headquartered in Rotselaar, Belguim.

Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets.

PharmaDM NV provides drug discovery data analysis solutions. It offers its solutions based on mining integrated chemical, biological, and clinical data. The firm's products include DMax, AlphaDMax, and IDMax. The company was founded by Dr. Luc Dehaspe, Dr. Ross D. King, and Dr. Ashwin Srinivasan in November 2000 and is headquartered in Heverlee, Belgium.

Founded in 1983, BNP Paribas Fortis Private Equity Expansion NV is a private equity firm that operates as a subsidiary of BNP Paribas SA. The company is based in Brussels, Belgium.

Aratana Therapeutics NV engages in the development and marketing of veterinary medicine. It offers Entyce, nocita, and Galliprant. The company was founded on December 20, 2007 and is headquartered in Leuven, Belgium.

Founded in 1989, BNP Paribas Fortis Private Equity Management NV is a market and opinion research agency based in Brussels, Belgium. Part of BNP Paribas SA, the Belgian company provides services in market and opinion research agency.